23 research outputs found
Quantification of myocardial blood flow with 82Rb positron emission tomography: clinical validation with 15O-water
Purpose: Quantification of myocardial blood flow (MBF) with generator-produced 82Rb is an attractive alternative for centres without an on-site cyclotron. Our aim was to validate 82Rb-measured MBF in relation to that measured using 15O-water, as a tracer 100% of which can be extracted from the circulation even at high flow rates, in healthy control subject and patients with mild coronary artery disease (CAD). Methods: MBF was measured at rest and during adenosine-induced hyperaemia with 82Rb and 15O-water PET in 33 participants (22 control subjects, aged 30â±â13years; 11 CAD patients without transmural infarction, aged 60â±â13years). A one-tissue compartment 82Rb model with ventricular spillover correction was used. The 82Rb flow-dependent extraction rate was derived from 15O-water measurements in a subset of 11 control subjects. Myocardial flow reserve (MFR) was defined as the hyperaemic/rest MBF. Pearson's correlation r, Bland-Altman 95% limits of agreement (LoA), and Lin's concordance correlation Ï c (measuring both precision and accuracy) were used. Results: Over the entire MBF range (0.66-4.7ml/min/g), concordance was excellent for MBF (râ=â0.90, [82Rb-15O-water] mean differenceâ±âSDâ=â0.04â±â0.66ml/min/g, LoAâ=ââ1.26 to 1.33ml/min/g, Ï câ=â0.88) and MFR (range 1.79-5.81, râ=â0.83, mean differenceâ=â0.14â±â0.58, LoAâ=ââ0.99 to 1.28, Ï câ=â0.82). Hyperaemic MBF was reduced in CAD patients compared with the subset of 11 control subjects (2.53â±â0.74 vs. 3.62â±â0.68ml/min/g, pâ=â0.002, for 15O-water; 2.53â±â1.01 vs. 3.82â±â1.21ml/min/g, pâ=â0.013, for 82Rb) and this was paralleled by a lower MFR (2.65â±â0.62 vs. 3.79â±â0.98, pâ=â0.004, for 15O-water; 2.85â±â0.91 vs. 3.88â±â0.91, pâ=â0.012, for 82Rb). Myocardial perfusion was homogeneous in 1,114 of 1,122 segments (99.3%) and there were no differences in MBF among the coronary artery territories (pâ>â0.31). Conclusion: Quantification of MBF with 82Rb with a newly derived correction for the nonlinear extraction function was validated against MBF measured using 15O-water in control subjects and patients with mild CAD, where it was found to be accurate at high flow rates. 82Rb-derived MBF estimates seem robust for clinical research, advancing a step further towards its implementation in clinical routin
Suppressing bladder artifacts in bone SPECT of the pelvis
Objective: Bladder-filling reconstruction artifacts have a detrimental effect on the image quality of pelvic bone single photon emission computed tomography (SPECT). Using a simple protocol consisting of forced diuresis coupled with intravenous (IV) hydration, this study was undertaken to obtain an artifact-free pelvic SPECT after discarding the residual urinary activity. Methods: Thirty patients were enrolled. In group I, pelvic SPECT was performed directly after normal void, whereas in group II, SPECT was preceded by IV injection of 0.5âmg/kg furosemide (maximum 40âmg) coupled with IV infusion of 500âcc of physiologic saline. Bladder-filling reconstruction artifacts were analyzed in group I patients, who had their images reconstructed using both filtered backprojection and iterative algorithms, both qualitatively and quantitatively by means of regions of interest (ROIs) drawn around the artifact-bearing bone areas as well as the corresponding contralateral sites. For group II patients, besides visual analysis, ROIs were placed over the sites corresponding to those of the group I patients. In every patient, total counts of each ROI were normalized to a reference ROI placed over the sacrum, and a ratio was created. Results: Using filtered backprojection, two forms of artifacts were identified in group I patients: first, a streak pattern that extended to the sacro-iliac joint in nine (60%) patients, the hip joint in five (33%), the superior pubic rami in four (27%), the sacrum in three (20%), and the ischium in one (6%); second, a count loss subtype which extended to the hip joints in nine (60%) patients. Corresponding values after iterative reconstruction were two (13%) for the sacro-iliac joint, three (20%) for the hip joint, one (6%) for the superior pubic ramus, and one (6%) for the sacrum. In five (33%) patients, residual count loss artifacts were still identifiable after iterative reconstruction. However in group II, no such effects were observed because the bladder activity reached near background level in 14 (93%) of 15 patients after three successive voids with a 3.5-fold decrease in the mean value of total bladder count in comparison with group I patients. A statistically significant difference was found between artifact- and non-artifact-harboring ROIs in group I whichever the method used for reconstruction, whereas the values of right and left hemi-pelvis ROIs/sacrum in group II were almost identical. Conclusions: Forced diuresis coupled with parenteral hydration facilitates the acquisition of an artifact-free pelvic SPECT. Especially for clinical questions that focus on femoral heads and pubic bones, applying the aforementioned protocol may improve the diagnostic accuracy of pelvic bone SPEC
Suppressing bladder artifacts in bone SPECT of the pelvis.
OBJECTIVE: Bladder-filling reconstruction artifacts have a detrimental effect on the image quality of pelvic bone single photon emission computed tomography (SPECT). Using a simple protocol consisting of forced diuresis coupled with intravenous (IV) hydration, this study was undertaken to obtain an artifact-free pelvic SPECT after discarding the residual urinary activity. METHODS: Thirty patients were enrolled. In group I, pelvic SPECT was performed directly after normal void, whereas in group II, SPECT was preceded by IV injection of 0.5 mg/kg furosemide (maximum 40 mg) coupled with IV infusion of 500 cc of physiologic saline. Bladder-filling reconstruction artifacts were analyzed in group I patients, who had their images reconstructed using both filtered backprojection and iterative algorithms, both qualitatively and quantitatively by means of regions of interest (ROIs) drawn around the artifact-bearing bone areas as well as the corresponding contralateral sites. For group II patients, besides visual analysis, ROIs were placed over the sites corresponding to those of the group I patients. In every patient, total counts of each ROI were normalized to a reference ROI placed over the sacrum, and a ratio was created. RESULTS: Using filtered backprojection, two forms of artifacts were identified in group I patients: first, a streak pattern that extended to the sacro-iliac joint in nine (60%) patients, the hip joint in five (33%), the superior pubic rami in four (27%), the sacrum in three (20%), and the ischium in one (6%); second, a count loss subtype which extended to the hip joints in nine (60%) patients. Corresponding values after iterative reconstruction were two (13%) for the sacro-iliac joint, three (20%) for the hip joint, one (6%) for the superior pubic ramus, and one (6%) for the sacrum. In five (33%) patients, residual count loss artifacts were still identifiable after iterative reconstruction. However in group II, no such effects were observed because the bladder activity reached near background level in 14 (93%) of 15 patients after three successive voids with a 3.5-fold decrease in the mean value of total bladder count in comparison with group I patients. A statistically significant difference was found between artifact- and non-artifact-harboring ROIs in group I whichever the method used for reconstruction, whereas the values of right and left hemi-pelvis ROIs/sacrum in group II were almost identical. CONCLUSIONS: Forced diuresis coupled with parenteral hydration facilitates the acquisition of an artifact-free pelvic SPECT. Especially for clinical questions that focus on femoral heads and pubic bones, applying the aforementioned protocol may improve the diagnostic accuracy of pelvic bone SPECT
Quantification of myocardial blood flow with 82Rb positron emission tomography: clinical validation with 15O-water
PURPOSE: Quantification of myocardial blood flow (MBF) with generator-produced (82)Rb is an attractive alternative for centres without an on-site cyclotron. Our aim was to validate (82)Rb-measured MBF in relation to that measured using (15)O-water, as a tracer 100% of which can be extracted from the circulation even at high flow rates, in healthy control subject and patients with mild coronary artery disease (CAD).
METHODS: MBF was measured at rest and during adenosine-induced hyperaemia with (82)Rb and (15)O-water PET in 33 participants (22 control subjects, aged 30 ± 13 years; 11 CAD patients without transmural infarction, aged 60 ± 13 years). A one-tissue compartment (82)Rb model with ventricular spillover correction was used. The (82)Rb flow-dependent extraction rate was derived from (15)O-water measurements in a subset of 11 control subjects. Myocardial flow reserve (MFR) was defined as the hyperaemic/rest MBF. Pearson's correlation r, Bland-Altman 95% limits of agreement (LoA), and Lin's concordance correlation Ï (c) (measuring both precision and accuracy) were used.
RESULTS: Over the entire MBF range (0.66-4.7 ml/min/g), concordance was excellent for MBF (r = 0.90, [(82)Rb-(15)O-water] mean difference ± SD = 0.04 ± 0.66 ml/min/g, LoA = -1.26 to 1.33 ml/min/g, Ï(c) = 0.88) and MFR (range 1.79-5.81, r = 0.83, mean difference = 0.14 ± 0.58, LoA = -0.99 to 1.28, Ï(c) = 0.82). Hyperaemic MBF was reduced in CAD patients compared with the subset of 11 control subjects (2.53 ± 0.74 vs. 3.62 ± 0.68 ml/min/g, p = 0.002, for (15)O-water; 2.53 ± 1.01 vs. 3.82 ± 1.21 ml/min/g, p = 0.013, for (82)Rb) and this was paralleled by a lower MFR (2.65 ± 0.62 vs. 3.79 ± 0.98, p = 0.004, for (15)O-water; 2.85 ± 0.91 vs. 3.88 ± 0.91, p = 0.012, for (82)Rb). Myocardial perfusion was homogeneous in 1,114 of 1,122 segments (99.3%) and there were no differences in MBF among the coronary artery territories (p > 0.31).
CONCLUSION: Quantification of MBF with (82)Rb with a newly derived correction for the nonlinear extraction function was validated against MBF measured using (15)O-water in control subjects and patients with mild CAD, where it was found to be accurate at high flow rates. (82)Rb-derived MBF estimates seem robust for clinical research, advancing a step further towards its implementation in clinical routine
La gestion des lentilles dâeau douce des Ăźles LoyautĂ© (Nouvelle-CalĂ©donie) : les programmes "Adage Lifou" et "Sage"
The ADAGE concept (Decision support in environmental development and management) was used in 1999 in Lifou (Loyalty Islands) to improve decision-making on exploitation of the lens freshwater resource. In the first part of the text are presented some aspects (geography, geology, ...) of the regional context of the Loyalty archipelago. The second part explains the pluridisciplinary ADAGE approach which construct an interface between the scientific knowledge and the needs of the society by an adapted translation of the scientific speech to the political speech. For example, we present the two main questions asked in hydrogeology by the Loyalty Islands population and the answers given by ADAGE. We explain the restitution results to the decision-makers, the custom authorities and population which allows to present the ADAGE concept as a model to promote the environmental protection actions in the insular Pacific area. The last part of the text presents the SAGE Program which expand the ADAGE program at the whole Loyalty Islands Province.Allenbach Michel, Lille Didier, Taladoire Gilles, Jost Christian. La gestion des lentilles dâeau douce des Ăźles LoyautĂ© (Nouvelle-CalĂ©donie) : les programmes "Adage Lifou" et "Sage". In: Les aires protĂ©gĂ©es insulaires et littorales tropicales. Actes du colloque DYMSET, TRANSCULTURES, SEPANRIT «Aires protĂ©gĂ©es insulaires et littorales tropicales», NoumĂ©a (Nouvelle-CalĂ©donie), 30 et 31 octobre 2001. Talence : Centre de Recherches sur les Espaces Tropicaux (UniversitĂ© Michel de Montaigne, Bordeaux 3), 2003. pp. 271-282. (Ăles et Archipels, 32
Added prognostic value of myocardial blood flow quantitation in rubidium-82 positron emission tomography imaging
AIMS: We studied the respective added value of the quantitative myocardial blood flow (MBF) and the myocardial flow reserve (MFR) as assessed with (82)Rb positron emission tomography (PET)/CT in predicting major adverse cardiovascular events (MACEs) in patients with suspected myocardial ischaemia. METHODS AND RESULTS: Myocardial perfusion images were analysed semi-quantitatively (SDS, summed difference score) and quantitatively (MBF, MFR) in 351 patients. Follow-up was completed in 335 patients and annualized MACE (cardiac death, myocardial infarction, revascularization, or hospitalization for congestive heart failure or de novo stable angor) rates were analysed with the Kaplan-Meier method in 318 patients after excluding 17 patients with early revascularizations (2) (n = 105) than those without [14% (95% CI = 9.1-22%) vs. 4.5% (2.7-7.4%), P < 0.0001]. The lowest MFR tertile group (MFR <1.8) had the highest MACE rate [16% (11-25%) vs. 2.9% (1.2-7.0%) and 4.3% (2.1-9.0%), P < 0.0001]. Similarly, the lowest stress MBF tertile group (MBF <1.8 mL/min/g) had the highest MACE rate [14% (9.2-22%) vs. 7.3% (4.2-13%) and 1.8% (0.6-5.5%), P = 0.0005]. Quantitation with stress MBF or MFR had a significant independent prognostic power in addition to semi-quantitative findings. The largest added value was conferred by combining stress MBF to SDS. This holds true even for patients without ischaemia. CONCLUSION: Perfusion findings in (82)Rb PET/CT are strong MACE outcome predictors. MBF quantification has an added value allowing further risk stratification in patients with normal and abnormal perfusion images
Dialectical behavior therapy skills training affects defense mechanisms in borderline personality disorder: An integrative approach of mechanisms in psychotherapy
Borderline personality disorder (BPD) is characterized by immature defense mechanisms. Dialectical behavior therapy (DBT) is an effective treatment for BPD. However, understanding the underlying mechanisms of change is still limited. Using a transtheoretical framework, we investigated the effect of DBT skills training on defense mechanisms.; In this randomized controlled trial, 16 of 31 BPD outpatients received DBT skills training adjunctive to individual treatment as usual (TAU), while the remaining 15 received only individual TAU. Pre-post changes of defense mechanisms, assessed with the Defense Mechanism Rating Scale, were compared between treatment conditions using ANCOVAs. Partial correlations and linear regressions were conducted to explore associations between defenses and symptom outcome.; Overall defense function improved significantly more in the skills training condition (F(1, 28)â=â4.57, pâ=â.041). Borderline defenses decreased throughout skills training, but not throughout TAU only (F(1, 28)â=â5.09, pâ=â.032). In the skills training condition, an increase in narcissistic defenses was associated with higher symptom scores at discharge (ÎČâ=â0.58, pâ=â.02).; Although DBT does not explicitly target defense mechanisms, skills training may have favorable effects on defense function in BPD. Our findings contribute to an integrative understanding of mechanisms of change in BPD psychotherapy
Appropriate use criteria for dementia amyloid imaging in Switzerland â mini-review and statement on behalf of the Swiss Society of Nuclear Medicine and the Swiss Memory Clinics
While FDG-PET imaging of the brain for the differential diagnosis of dementia has been covered by the compulsory health insurance in Switzerland for more than a decade, beta-amyloid-PET just recently has been added to the catalogue of procedures that have been cleared for routine use, provided that a set of appropriate use criteria (AUC) be followed. To provide guidance to dementia care practitioners, the Swiss Society of Nuclear Medicine and the Swiss Memory Clinics jointly report a mini-review on beta-amyloid-PET and discuss the AUC set into effect by the Swiss Federal Office of Public Health, as well as their application and limitations.Die Beta-Amyloid-PET-Bildgebung des Gehirns ist mit der Zulassung fĂŒr die klinische Routineanwendung durch Swissmedic von 3 EU-weit bereits lĂ€nger kommerziell verfĂŒgbaren Amyloid-ÎČ-PET-Radiopharmaka nun auch in dem Nicht-EU-Land Schweiz allgemein verfĂŒgbar geworden. Seit dem 01.04.2020 unterliegt die Anwendung von Beta-Amyloid-PET der gesetzlichen Leistungspflicht durch die obligatorische Schweizer Krankenversicherung fĂŒr die Differenzialdiagnose demenzieller Erkrankungen unter bestimmten Voraussetzungen.Im Namen der Schweizer Gesellschaft fĂŒr Nuklearmedizin (SGNM) und der Schweizer Memory-Kliniken publiziert die AG Neuronuklearmedizin der SGNM die aktuell gĂŒltigen Anwendungskriterien im Rahmen der gesetzlichen Leistungspflicht in der Schweiz, um sowohl den verordnenden Demenzspezialisten, Gerontopsychiatern und Neurologen, als auch den durchfĂŒhrenden Nuklearmedizinern Handlungsempfehlung an die Hand zu geben und einen aktuellen KurzĂŒberblick ĂŒber Möglichkeiten und Grenzen der Beta-Amyloid-Bildgebung im klinischen Alltagskontext zu geben
Value of positron emission tomography in full-thickness chest wall resections for malignancies
Rapport de synthĂšse :
Les tumeurs de la paroi thoracique sont des pathologies graves dont le traitement principal consiste en une rĂ©section chirurgicale. L'enjeu majeur de cette intervention ontologique est de rĂ©sĂ©quer la totalitĂ© de la tumeur, ce qui nĂ©cessite une planification prĂ©opĂ©ratoire minutieuse. Classiquement, l'identification et la localisation de la tumeur se fait Ă l'aide de la tomodensitomĂ©trie (computed tomography, CT) ou de l'imagerie par rĂ©sonnance magnĂ©tique (1RM). Actuellement, l'imagerie nuclĂ©aire fonctionnelle par tomographie par Ă©mission de positons (positron emission tomography, PET) qui peut ĂȘtre couplĂ©e au CT (PET/CT) est de plus en plus appliquĂ©e aux patients prĂ©sentant une tumeur maligne. Son efficacitĂ© a frĂ©quemment Ă©tĂ© dĂ©montrĂ©e.
Le but de la présente étude est d'évaluer la valeur du PET dans la planification de la résection des tumeurs de la paroi thoracique. Une analyse rétrospective de dix-huit patients opérés entre 2004 et 2006 a été réalisée; Dans ce groupe de patient, la taille de la tumeur mesurée sur la piÚce opératoire réséquée a été comparée à la taille de la tumeur mesurée sur le CT et le PET. Les résultats démontrent que le CT surestimait de maniÚre consistante la taille réelle de la tumeur par rapport au PET (+64% par rapport à +1%, P<0.001). De plus, le PET s'est avéré particuliÚrement performant pour prédire la taille des tumeurs de plus de 5.5 cm de diamÚtre par rapport au CT (valeur prédictive positive 80% par rapport à 44% et spécificité 93% par apport à 64%, respectivement).
Cette étude démontre que le PET permettrait de mesurer la taille des tumeurs de la paroi thoracique de maniÚre plus précise que le CT. Cette nouvelle modalité diagnostique s'avÚrerait donc utile pour planifier les résections chirurgicales de telles tumeurs. A notre connaissance, aucune publication ne décrit la valeur du PET dans ce domaine. Les performances accrues du PET permettraient une meilleure délimitation des tumeurs ce qui améliorerait la précision de la résection chirurgicale.
En conclusion, cette Ă©tude prĂ©liminaire rĂ©trospective dĂ©montre la faisabilitĂ© du PET pour les tumeurs de la paroi thoracique. Ces rĂ©sultats devraient ĂȘtre confirmĂ©s par une Ă©tude prospective incluant un plus grand nombre de patients avec la perspective de juger l'impact clinique rĂ©el du PET sur la prise en charge thĂ©rapeutique des patients